Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans.

Kurtz CB, Millet YA, Puurunen MK, Perreault M, Charbonneau MR, Isabella VM, Kotula JW, Antipov E, Dagon Y, Denney WS, Wagner DA, West KA, Degar AJ, Brennan AM, Miller PF.

Sci Transl Med. 2019 Jan 16;11(475). pii: eaau7975. doi: 10.1126/scitranslmed.aau7975.

PMID:
30651324
2.

Determination of in situ biodegradation rates via a novel high resolution isotopic approach in contaminated sediments.

Gilevska T, Passeport E, Shayan M, Seger E, Lutz EJ, West KA, Morgan SA, Mack EE, Sherwood Lollar B.

Water Res. 2019 Feb 1;149:632-639. doi: 10.1016/j.watres.2018.11.029. Epub 2018 Nov 15.

PMID:
30583106
3.

Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis.

Szymanski JM, Waldman M, Conry-Cantilena C, West KA.

J Clin Apher. 2019 Aug;34(4):495-498. doi: 10.1002/jca.21677. Epub 2018 Dec 10.

PMID:
30537217
4.

Effectiveness of a Web-Based eHealth Portal for Delivery of Care to Home Dialysis Patients: A Single-Arm Pilot Study.

Kiberd J, Khan U, Stockman C, Radhakrishnan A, Phillips M, Kiberd BA, West KA, Soroka S, Chan C, Tennankore KK.

Can J Kidney Health Dis. 2018 Sep 7;5:2054358118794415. doi: 10.1177/2054358118794415. eCollection 2018.

5.

Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria.

Isabella VM, Ha BN, Castillo MJ, Lubkowicz DJ, Rowe SE, Millet YA, Anderson CL, Li N, Fisher AB, West KA, Reeder PJ, Momin MM, Bergeron CG, Guilmain SE, Miller PF, Kurtz CB, Falb D.

Nat Biotechnol. 2018 Oct;36(9):857-864. doi: 10.1038/nbt.4222. Epub 2018 Aug 13.

PMID:
30102294
6.

Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use.

Morton S, Stanworth S, Lozano M, Harrison SJ, Hong FS, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner JM, Yokoyama APH, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry-Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D.

Vox Sang. 2017 Oct;112(7):e48-e68. doi: 10.1111/vox.12523. Epub 2017 Sep 14. No abstract available.

PMID:
28905396
7.

Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use: summary.

Morton S, Stanworth S, Lozano M, Harrison SJ, Hong FS, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner JM, Yokoyama APH, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry-Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D.

Vox Sang. 2017 Oct;112(7):680-683. doi: 10.1111/vox.12522. Epub 2017 Sep 14. No abstract available.

PMID:
28905391
8.

Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection.

Sheela S, Ito S, Strich JR, Manion M, Montemayor-Garcia C, Wang HW, Oetjen KA, West KA, Barrett AJ, Parta M, Gea-Banacloche J, Holland SM, Hourigan CS, Lai C.

Leuk Res Rep. 2017 Jul 18;8:4-6. doi: 10.1016/j.lrr.2017.07.001. eCollection 2017.

9.

Granulocyte transfusions in the management of invasive fungal infections.

West KA, Gea-Banacloche J, Stroncek D, Kadri SS.

Br J Haematol. 2017 May;177(3):357-374. doi: 10.1111/bjh.14597. Epub 2017 Mar 14. Review.

10.

Autologous lymphapheresis for the production of chimeric antigen receptor T cells.

Allen ES, Stroncek DF, Ren J, Eder AF, West KA, Fry TJ, Lee DW, Mackall CL, Conry-Cantilena C.

Transfusion. 2017 May;57(5):1133-1141. doi: 10.1111/trf.14003. Epub 2017 Feb 24.

11.

Trends in Hospitalizations With a Red Blood Cell Transfusion, 2000–2013: Statistical Brief #215.

West KA, Barrett ML, Moore BJ, Miller JL, Steiner CA.

Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb-. No abstract available.
2016 Dec.

12.

Accepting hereditary hemochromatosis blood donors: ask not why, ask why not.

West KA, Eder AF.

Transfusion. 2016 Dec;56(12):2907-2909. doi: 10.1111/trf.13919. No abstract available.

PMID:
27933629
13.

International Forum regarding practices related to donor haemoglobin and iron.

Goldman M, Magnussen K, Gorlin J, Lozano M, Speedy J, Keller A, Pink J, Leung JN, Chu CC, Lee CK, Faed J, Chay J, Tan HH, Teo D, Djoudi R, Woimant G, Fillet AM, Castrén J, Miflin G, Vandewalle GC, Compernolle V, Cardenas JM, Infanti L, Holbro A, Buser A, van den Hurk K, Yahalom VJ, Gendelman V, Shinar E, Eder AF, Steele WR, O'Neill EM, Kamel H, Vassallo R, Delage G, Lebrun A, Robillard P, Germain M, Gandhi M, West KA, Klein HG.

Vox Sang. 2016 Nov;111(4):449-455. doi: 10.1111/vox.12431. Epub 2016 Aug 26. No abstract available.

PMID:
27564140
14.

A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models.

Chan-Penebre E, Kuplast KG, Majer CR, Boriack-Sjodin PA, Wigle TJ, Johnston LD, Rioux N, Munchhof MJ, Jin L, Jacques SL, West KA, Lingaraj T, Stickland K, Ribich SA, Raimondi A, Scott MP, Waters NJ, Pollock RM, Smith JJ, Barbash O, Pappalardi M, Ho TF, Nurse K, Oza KP, Gallagher KT, Kruger R, Moyer MP, Copeland RA, Chesworth R, Duncan KW.

Nat Chem Biol. 2015 Jun;11(6):432-7. doi: 10.1038/nchembio.1810. Epub 2015 Apr 27.

PMID:
25915199
15.

HSP90 inhibition enhances antimitotic drug-induced mitotic arrest and cell death in preclinical models of non-small cell lung cancer.

O'Connell BC, O'Callaghan K, Tillotson B, Douglas M, Hafeez N, West KA, Stern H, Ali JA, Changelian P, Fritz CC, Palombella VJ, McGovern K, Kutok JL.

PLoS One. 2014 Dec 26;9(12):e115228. doi: 10.1371/journal.pone.0115228. eCollection 2014.

16.

Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study.

Cid J, Lozano M, Ziman A, West KA, O'Brien KL, Murphy MF, Wendel S, Vázquez A, Ortín X, Hervig TA, Delaney M, Flegel WA, Yazer MH; Biomedical Excellence for Safer Transfusion collaborative.

Br J Haematol. 2015 Feb;168(4):598-603. doi: 10.1111/bjh.13158. Epub 2014 Oct 4.

17.

Transfusion medicine illustrated: Muddy waters in therapeutic plasma exchange.

West KA, Leitman SF, Flegel WA.

Transfusion. 2014 Sep;54(9):2157. doi: 10.1111/trf.12601. No abstract available.

18.

Evidence that the LRRK2 ROC domain Parkinson's disease-associated mutants A1442P and R1441C exhibit increased intracellular degradation.

Greene ID, Mastaglia F, Meloni BP, West KA, Chieng J, Mitchell CJ, Gai WP, Boulos S.

J Neurosci Res. 2014 Apr;92(4):506-16. doi: 10.1002/jnr.23331. Epub 2013 Dec 24.

PMID:
24375786
19.

Isolation of two new Dehalococcoides mccartyi strains with dissimilar dechlorination functions and their characterization by comparative genomics via microarray analysis.

Lee PK, Cheng D, West KA, Alvarez-Cohen L, He J.

Environ Microbiol. 2013 Aug;15(8):2293-305. doi: 10.1111/1462-2920.12099. Epub 2013 Mar 11.

PMID:
23480482
20.

Global gene expression of Dehalococcoides within a robust dynamic TCE-dechlorinating community under conditions of periodic substrate supply.

West KA, Lee PK, Johnson DR, Zinder SH, Alvarez-Cohen L.

Biotechnol Bioeng. 2013 May;110(5):1333-41. doi: 10.1002/bit.24819. Epub 2013 Feb 9.

PMID:
23280440
21.

Adequacy of lymph node harvesting in colorectal cancer management: improving standards, ensuring quality.

Graham RP, Plummer JM, West KA, Williams NP.

West Indian Med J. 2012 Mar;61(2):134-8.

PMID:
23155957
22.

Metagenomic analysis of a stable trichloroethene-degrading microbial community.

Brisson VL, West KA, Lee PK, Tringe SG, Brodie EL, Alvarez-Cohen L.

ISME J. 2012 Sep;6(9):1702-14. doi: 10.1038/ismej.2012.15. Epub 2012 Mar 1.

23.

Hedgehog-Gli pathway activation during kidney fibrosis.

Fabian SL, Penchev RR, St-Jacques B, Rao AN, Sipilä P, West KA, McMahon AP, Humphreys BD.

Am J Pathol. 2012 Apr;180(4):1441-53. doi: 10.1016/j.ajpath.2011.12.039. Epub 2012 Feb 17.

24.

Starting with the ABCs: Akt in breast cancer.

West KA, Dennis PA.

Mol Cancer Ther. 2011 Nov;10(11):2031. doi: 10.1158/1535-7163.MCT-11-0712. No abstract available.

25.

Sustainable syntrophic growth of Dehalococcoides ethenogenes strain 195 with Desulfovibrio vulgaris Hildenborough and Methanobacterium congolense: global transcriptomic and proteomic analyses.

Men Y, Feil H, Verberkmoes NC, Shah MB, Johnson DR, Lee PK, West KA, Zinder SH, Andersen GL, Alvarez-Cohen L.

ISME J. 2012 Feb;6(2):410-21. doi: 10.1038/ismej.2011.111. Epub 2011 Sep 1.

26.

Pharmacokinetic-pharmacodynamic analysis of vismodegib in preclinical models of mutational and ligand-dependent Hedgehog pathway activation.

Wong H, Alicke B, West KA, Pacheco P, La H, Januario T, Yauch RL, de Sauvage FJ, Gould SE.

Clin Cancer Res. 2011 Jul 15;17(14):4682-92. doi: 10.1158/1078-0432.CCR-11-0975. Epub 2011 May 24.

27.

Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study.

Tennankore KK, Soroka SD, West KA, Kiberd BA.

BMC Nephrol. 2011 May 11;12:19. doi: 10.1186/1471-2369-12-19.

28.

Antitumor activity of the Hsp90 inhibitor IPI-504 in HER2-positive trastuzumab-resistant breast cancer.

Scaltriti M, Serra V, Normant E, Guzman M, Rodriguez O, Lim AR, Slocum KL, West KA, Rodriguez V, Prudkin L, Jimenez J, Aura C, Baselga J.

Mol Cancer Ther. 2011 May;10(5):817-24. doi: 10.1158/1535-7163.MCT-10-0966. Epub 2011 Mar 7.

29.

The Hsp90 inhibitor IPI-504 rapidly lowers EML4-ALK levels and induces tumor regression in ALK-driven NSCLC models.

Normant E, Paez G, West KA, Lim AR, Slocum KL, Tunkey C, McDougall J, Wylie AA, Robison K, Caliri K, Palombella VJ, Fritz CC.

Oncogene. 2011 Jun 2;30(22):2581-6. doi: 10.1038/onc.2010.625. Epub 2011 Jan 24.

PMID:
21258415
30.

Comparative genomics of two newly isolated Dehalococcoides strains and an enrichment using a genus microarray.

Lee PK, Cheng D, Hu P, West KA, Dick GJ, Brodie EL, Andersen GL, Zinder SH, He J, Alvarez-Cohen L.

ISME J. 2011 Jun;5(6):1014-24. doi: 10.1038/ismej.2010.202. Epub 2011 Jan 13.

31.

Hsp90 (heat shock protein 90) inhibitor occupancy is a direct determinant of client protein degradation and tumor growth arrest in vivo.

Tillotson B, Slocum K, Coco J, Whitebread N, Thomas B, West KA, MacDougall J, Ge J, Ali JA, Palombella VJ, Normant E, Adams J, Fritz CC.

J Biol Chem. 2010 Dec 17;285(51):39835-43. doi: 10.1074/jbc.M110.141580. Epub 2010 Oct 12.

32.

The Ca(2+) channel blocker flunarizine induces caspase-10-dependent apoptosis in Jurkat T-leukemia cells.

Conrad DM, Furlong SJ, Doucette CD, West KA, Hoskin DW.

Apoptosis. 2010 May;15(5):597-607. doi: 10.1007/s10495-010-0454-3.

PMID:
20094800
33.

Multiple myeloma presenting as cervical lymphadenopathy in a 16-year-old boy.

Brady-West DC, Buchner-Daley LM, McGrowder DA, Taylor-Houston J, West KA.

J Natl Med Assoc. 2009 Aug;101(8):810-2.

PMID:
19715046
34.

Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis.

Schoeberl B, Pace EA, Fitzgerald JB, Harms BD, Xu L, Nie L, Linggi B, Kalra A, Paragas V, Bukhalid R, Grantcharova V, Kohli N, West KA, Leszczyniecka M, Feldhaus MJ, Kudla AJ, Nielsen UB.

Sci Signal. 2009 Jun 30;2(77):ra31. doi: 10.1126/scisignal.2000352.

35.

Vav1 regulates the migration and adhesion of dendritic cells.

Spurrell DR, Luckashenak NA, Minney DC, Chaplin A, Penninger JM, Liwski RS, Clements JL, West KA.

J Immunol. 2009 Jul 1;183(1):310-8. doi: 10.4049/jimmunol.0802096.

36.

Primary epithelial tumours of the appendix in a black population: a review of cases.

Graham RP, Williams NP, West KA.

World J Gastroenterol. 2009 Mar 28;15(12):1472-4.

37.

Role of activated protein C and its receptor in inhibition of tumor metastasis.

Bezuhly M, Cullen R, Esmon CT, Morris SF, West KA, Johnston B, Liwski RS.

Blood. 2009 Apr 2;113(14):3371-4. doi: 10.1182/blood-2008-05-159434. Epub 2009 Feb 2.

38.

Activated protein C improves ischemic flap survival and modulates proangiogenic and antiinflammatory gene expression.

Bezuhly M, Morris SF, Juskevicius R, Currie RW, West KA, Liwski RS.

Plast Reconstr Surg. 2009 Feb;123(2):502-15. doi: 10.1097/PRS.0b013e318196b87f.

PMID:
19182607
39.

ABRF-PRG05: de novo peptide sequence determination.

Falick AM, Kowalak JA, Lane WS, Phinney BS, Turck CW, Weintraub ST, West KA, Neubert TA.

J Biomol Tech. 2008 Sep;19(4):251-7.

40.

Activated protein C: an emerging therapeutic agent in the prevention of ischemia-reperfusion injury.

Bezuhly M, Liwski R, West KA, Morris SF.

J Reconstr Microsurg. 2008 Jul;24(5):361-7. doi: 10.1055/s-2008-1080540. Epub 2008 Jul 2. Review.

PMID:
18597223
41.

Amino acid analysis.

Crabb JW, West KA, Dodson WS, Hulmes JD.

Curr Protoc Protein Sci. 2001 May;Chapter 11:Unit 11.9. doi: 10.1002/0471140864.ps1109s07.

PMID:
18429107
42.

Expression of a functional single-chain variable-fragment antibody against complement receptor 1 in Streptococcus gordonii.

Knight JB, Halperin SA, West KA, Lee SF.

Clin Vaccine Immunol. 2008 Jun;15(6):925-31. doi: 10.1128/CVI.00500-07. Epub 2008 Apr 2.

43.

Comparative genomics of "Dehalococcoides ethenogenes" 195 and an enrichment culture containing unsequenced "Dehalococcoides" strains.

West KA, Johnson DR, Hu P, DeSantis TZ, Brodie EL, Lee PK, Feil H, Andersen GL, Zinder SH, Alvarez-Cohen L.

Appl Environ Microbiol. 2008 Jun;74(11):3533-40. doi: 10.1128/AEM.01835-07. Epub 2008 Mar 21.

44.

ABRF-PRG04: differentiation of protein isoforms.

Arnott D, Gawinowicz MA, Kowalak JA, Lane WS, Speicher KD, Turck CW, West KA, Neubert TA.

J Biomol Tech. 2007 Apr;18(2):124-34.

45.

Prolonged costimulation is required for naive T cell activation.

Liwski RS, Chase JC, Baldridge WH, Sadek I, Rowden G, West KA.

Immunol Lett. 2006 Aug 15;106(2):135-43.

PMID:
16769127
46.

Phylogenetic analysis of TCE-dechlorinating consortia enriched on a variety of electron donors.

Freeborn RA, West KA, Bhupathiraju VK, Chauhan S, Rahm BG, Richardson RE, Alvarez-Cohen L.

Environ Sci Technol. 2005 Nov 1;39(21):8358-68.

PMID:
16294874
48.

Proteomic characterization of isolated retinal pigment epithelium microvilli.

Bonilha VL, Bhattacharya SK, West KA, Sun J, Crabb JW, Rayborn ME, Hollyfield JG.

Mol Cell Proteomics. 2004 Nov;3(11):1119-27. Epub 2004 Sep 14.

49.

Support for a proposed retinoid-processing protein complex in apical retinal pigment epithelium.

Bonilha VL, Bhattacharya SK, West KA, Crabb JS, Sun J, Rayborn ME, Nawrot M, Saari JC, Crabb JW.

Exp Eye Res. 2004 Sep;79(3):419-22.

PMID:
15336505
50.

Retinal degeneration caused by mutations in TULP1.

Xi Q, Pauer GJ, West KA, Crabb JW, Hagstrom SA.

Adv Exp Med Biol. 2003;533:303-8. No abstract available.

PMID:
15180277

Supplemental Content

Support Center